Related references
Note: Only part of the references are listed.No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity
Gerui Li et al.
CLINICAL RESEARCH IN CARDIOLOGY (2021)
COVID-19 and the cardiovascular system
Ying-Ying Zheng et al.
NATURE REVIEWS CARDIOLOGY (2020)
Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction
Masatake Kobayashi et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
Bo Li et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association
Dhanunjaya R. Lakkireddy et al.
HEART RHYTHM (2020)
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
Jing Yang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis
Giuseppe Lippi et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2020)
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
Riccardo M. Inciardi et al.
JAMA CARDIOLOGY (2020)
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
Shaobo Shi et al.
JAMA CARDIOLOGY (2020)
Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China
Qing Deng et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Acetazolamide, Nifedipine Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19)
Isaac Solaimanzadeh
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function
Ignatios Ikonomidis et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Assessment of pulmonary artery pressure by echocardiography-A comprehensive review
Sathish Parasuraman et al.
IJC HEART & VASCULATURE (2016)
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Roberto M. Lang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2015)
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Rick A. Nishimura et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease)
Patrizio Lancellotti et al.
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY (2010)
European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)
Patrizio Lancellotti et al.
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY (2010)
Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndrome
Ednan K. Bajwa et al.
CRITICAL CARE MEDICINE (2007)